Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:03 +0200Mon, 24 Jun 2024 15:10:00 +0200Human medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/constellaHuman medicines European public assessment report (EPAR): Constella, linaclotide, Date of authorisation: 26/11/2012, Revision: 26, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/constellaMon, 24 Jun 2024 15:10:00 +0200Human medicineConstella-H-C-2490-PSUV-09 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500162652_en.pdfConstella-H-C-2490-PSUV-09 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500162652_en.pdfMon, 10 Mar 2014 01:00:00 +0100Human medicine